[Human immunodeficiency virus and Chagas disease coinfection treated successfully with benznidazole and a raltegravir-based antiretroviral regimen: a case report]

MeSH terms

• Adenine / administration & dosage
• Adenine / analogs & derivatives
• Adenine / pharmacokinetics
• Adenine / therapeutic use
• Adult
• Anti-HIV Agents / administration & dosage
• Anti-HIV Agents / pharmacokinetics
• Anti-HIV Agents / therapeutic use*
• Antiretroviral Therapy, Highly Active
• Atazanavir Sulfate
• Chagas Disease / complications
• Chagas Disease / drug therapy*
• Drug Interactions
• Drug Therapy, Combination
• Female
• HIV Infections / complications
• HIV Infections / drug therapy*
• Humans
• Lamivudine / administration & dosage
• Lamivudine / pharmacokinetics
• Lamivudine / therapeutic use
• Nitroimidazoles / administration & dosage
• Nitroimidazoles / pharmacokinetics
• Nitroimidazoles / therapeutic use*
• Oligopeptides / administration & dosage
• Oligopeptides / pharmacokinetics
• Oligopeptides / therapeutic use
• Organophosphonates / administration & dosage
• Organophosphonates / pharmacokinetics
• Organophosphonates / therapeutic use
• Paraguay / ethnology
• Pyridines / administration & dosage
• Pyridines / pharmacokinetics
• Pyridines / therapeutic use
• Pyrrolidinones / administration & dosage
• Pyrrolidinones / pharmacokinetics
• Pyrrolidinones / therapeutic use*
• Raltegravir Potassium
• Ritonavir / administration & dosage
• Ritonavir / pharmacokinetics
• Ritonavir / therapeutic use
• Spain
• Tenofovir
• Trypanocidal Agents / administration & dosage
• Trypanocidal Agents / pharmacokinetics
• Trypanocidal Agents / therapeutic use*
• Zidovudine / administration & dosage
• Zidovudine / pharmacokinetics
• Zidovudine / therapeutic use